Replies to post #4523 on GTC Biotherapeutics (fka GTCB)

[keitern]

Biggest item for me was the low cash burn, which IMO could be reduced even more if Atryn gets better than expected acceptance. At any rate, the dillitive effects of the recent past could be lessened IMO.